Receives Tagrisso Boost in Lung Cancer Trials

finance.yahoo.com/news/astrazeneca-plc-azn-receives-tagrisso-130338740.html

AstraZeneca PLC (NASDAQ:AZN) is one of the best defensive stocks to buy, according to Steve Cohen. On September 7, the company announced positive clinical trial results involving Tagrisso in combination with pemetrexed and platinum-based chemotherapy.
Pixabay/Public Domain
The trial…

This story appeared on finance.yahoo.com, 2025-09-15 13:03:38.
The Entire Business World on a Single Page. Free to Use →